As ADCs continue to show sustained success clinically and commercially, the 15^th World ADC San Diego returned as your world-leading, comprehensive forum offering data-driven insights, case study presentations, and informative discussions led by forward-thinking ADC industry pioneers to address the challenges and opportunities to bring an ADC from bench to bedside.

Built with the industry’s specific needs in mind, this year’s agenda had end-to-end ADC content for everyone, from discovering innovations in linker-payload design, assessing novel targets, accelerating through preclinical and clinical development whilst overcoming associated toxicity challenges, benchmarking best approaches in combination strategies, to enhancing analytical and process development to ensure product quality and optimize CMC strategy.

Whether attendees were a novice to the ADC field or a long-standing expert, they didn’t miss their annual ADC melting pot of innovation, collaboration, and inspiration to progress ADC development to new standard of care treatments in oncology and beyond, including content covering: